Alcohol Withdrawal Management
Benzodiazepines are the gold standard treatment for alcohol withdrawal syndrome and should be used in all patients with moderate to severe symptoms to prevent seizures, delirium tremens, and death. 1, 2
Assessment and Risk Stratification
Initial Evaluation
Evaluate for serious complications requiring immediate inpatient admission 1:
- History of withdrawal seizures or delirium tremens
- Significant current withdrawal symptoms
- High levels of recent drinking
- Serious medical comorbidities (liver failure, respiratory failure, head trauma, advanced age, obesity)
- Serious psychiatric illness
- Failed outpatient treatment
Severity Assessment Tools
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is useful for monitoring severity and guiding treatment, but should not be used for diagnosis 1. CIWA-Ar can be falsely elevated in conditions mimicking withdrawal (anxiety disorders, sepsis, hepatic encephalopathy, severe pain) 1. A CIWA-Ar score >8 indicates moderate withdrawal; ≥15 indicates severe withdrawal 2.
Important caveat: Scales incorporating vital signs are associated with longer treatment duration without reducing complications compared to CIWA-Ar 3.
Comorbidity Screening
Carefully evaluate for 1:
- Dehydration and electrolyte imbalances (especially magnesium)
- Renal failure
- Infection
- Gastrointestinal bleeding
- Pancreatitis
- Head trauma
- Hepatic encephalopathy
Pharmacologic Management Algorithm
First-Line Treatment: Benzodiazepines
For most patients (no liver disease, younger age, no respiratory compromise) 1, 2:
- Long-acting benzodiazepines provide superior seizure and delirium prevention
- Chlordiazepoxide: 25-100 mg PO every 4-6 hours
- Diazepam: 5-10 mg PO/IV/IM every 6-8 hours
For high-risk patients (severe withdrawal, advanced age, liver failure, respiratory failure, obesity, recent head trauma) 1:
- Lorazepam: 1-4 mg PO/IV/IM every 4-8 hours
- Starting dose: 6-12 mg/day, tapered after symptom resolution
Dosing strategy: Use symptom-triggered regimens rather than fixed-dose schedules to prevent drug accumulation and reduce treatment duration 2, 4.
Essential Adjunctive Therapy: Thiamine
All patients with alcohol withdrawal must receive thiamine to prevent Wernicke encephalopathy 1:
- Prevention: 100-300 mg/day for 4-12 weeks
- Treatment of Wernicke encephalopathy: 100-500 mg/day for 12-24 weeks
Critical timing: Administer thiamine before giving IV fluids containing glucose, as glucose can precipitate acute thiamine deficiency 1.
Alternative Agents
Carbamazepine 1:
- 200 mg PO every 6-8 hours
- Alternative to benzodiazepines for seizure prevention
- May be used for mild to moderate withdrawal 5
Haloperidol 1:
- 0.5-5 mg PO every 8-12 hours or 2-5 mg IM
- Only as adjunctive therapy for agitation or hallucinations not controlled by benzodiazepines
- Never as monotherapy
Phenobarbital: Emerging evidence shows lower rates of seizures and delirium tremens compared to benzodiazepines, though with higher critical care utilization 6. Consider for refractory cases.
Supportive Care
Provide 1:
- IV fluids for hydration
- Electrolyte replacement (especially magnesium)
- Vitamins
- Comfortable, quiet environment
- Frequent vital sign monitoring
Disposition and Follow-up
Inpatient vs Outpatient
Outpatient treatment is cost-effective with equivalent 6-month abstinence rates for uncomplicated cases 1. However, admit for inpatient treatment if 1:
- Delirium tremens
- Withdrawal seizures
- Physical or psychological comorbidities
- Failed outpatient management
Psychiatric Consultation
Psychiatric consultation is strongly recommended (A1 recommendation) for 1:
- Evaluation and acute management
- Long-term abstinence planning
- Assessment of alcohol use disorder severity
Duration of Monitoring
Monitor outpatients daily for up to 5 days after last drink to verify symptom improvement and assess need for additional treatment 5.
Common Pitfalls to Avoid
- Do not use CIWA-Ar for diagnosis—only for severity assessment and treatment monitoring 1
- Do not use phenothiazines as monotherapy—they are less effective than benzodiazepines for preventing delirium (P=0.002) and seizures (P<0.001) 4
- Do not forget thiamine before glucose administration—this can precipitate Wernicke encephalopathy 1
- Do not use benzodiazepines or clomethiazole beyond 10-14 days—risk of abuse in this population 2
- Do not use lorazepam in all patients—reserve for those with specific risk factors (liver disease, elderly, respiratory compromise) 1